SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-025658
Filing Date
2022-02-22
Accepted
2022-02-22 16:21:47
Documents
15
Period of Report
2022-02-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm227201d1_8k.htm   iXBRL 8-K 28036
2 EXHIBIT 99.1 tm227201d1_ex99-1.htm EX-99.1 89139
3 EXHIBIT 99.2 tm227201d1_ex99-2.htm EX-99.2 32769
7 GRAPHIC tm227201d1_ex99-2img001.jpg GRAPHIC 3774
  Complete submission text file 0001104659-22-025658.txt   356006

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA atxs-20220217.xsd EX-101.SCH 3036
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxs-20220217_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxs-20220217_pre.xml EX-101.PRE 22597
9 EXTRACTED XBRL INSTANCE DOCUMENT tm227201d1_8k_htm.xml XML 3612
Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 22658368
SIC: 2834 Pharmaceutical Preparations